Clinical Trials Logo
  1. Home
  2. No-Reflow Phenomenon
  3. NCT04785209

Mean Platelet Volume and STEMI Clinical Risk Scores in Prediction of Impaired Myocardial Perfusion In Acute STEMI Patients Undergoing Primary Percutaneous Coronary Intervention.

No-Reflow Phenomenon Clinical Trial

Official title:
Mean Platelet Volume and STEMI Clinical Risk Scores in Prediction of Impaired Myocardial Perfusion In Acute STEMI Patients Undergoing PPCI.

Clinical Trial Summary

Predicting no reflow in ppci of STEMI patients using mean platelet volume together with STEMI clinical risk scores

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04785209
Study type Observational
Source Assiut University
Contact
Status Completed
Phase
Start date September 1, 2020
Completion date May 1, 2024
View Details
See also
  Status Clinical Trial Phase
Not yet recruiting NCT03264859 - NGAL and Its Association With the No-reflow Phenomenon in ST-elevation Myocardial Infarction N/A
Not yet recruiting NCT06342141 - Empagliflozin for No-reflow Phenomenon in PCI for STEMI Phase 2
Not yet recruiting NCT04835974 - the No-reflow in Diabetic Patients Treated With Primary Percutaneous Coronary Intervention (PCI) N/A
Not yet recruiting NCT05360602 - Alpha Lipoic Acid Effect on No-Reflow Phenomenon N/A
Completed NCT02054000 - Intracoronary Tirofiban on No-Reflow Phenomena Phase 4
Not yet recruiting NCT05393557 - Upfront Premedication For Reduction of Microvascular Obstruction and No-reflow in Treating ST-segment Elevation Myocardial Infarction N/A
Completed NCT04699110 - Adrenaline for the Treatment of No-Reflow in Normotensive Patients Phase 4
Completed NCT04573751 - The EPIVER Randomized Controlled Trial N/A
Not yet recruiting NCT02233790 - Ticagrelor and Clopidogrel on Reperfusion in Patients With AMI Phase 4
Recruiting NCT05427786 - A Study to Evaluate the Impact of Pre-procedural Intracoronary Nicorandil Injection to PREVENT reductioN Of decREased TIMI FLOW in Patients Who Undergoing Percutaneous Coronary Intervention for the Coronary Artery Disease Phase 4
Completed NCT05355532 - Genetic Determinants of the Coronary Microvascular Obstruction in PCI